Insider Trading & Ownership - Myers Jason W.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Myers Jason W.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-23
Sale
2020-12-28
9:40 pm
Invitae Corp NVTA Myers Jason W.
President, Oncology
174,152 $50.93 $8,868,878 410,597
(Direct)
View
2020-12-21
Sale
2020-12-23
5:24 pm
Invitae Corp NVTA Myers Jason W.
President, Oncology
224,965 $51.55 $11,597,140 584,749
(Direct)
View
2020-12-16
Sale
2020-12-18
9:32 pm
Invitae Corp NVTA Myers Jason W.
President, Oncology
253,912 $47.49 $12,058,436 809,714
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-16
Option Award
2022-06-21
09:42 am
N/A
2032-06-16
IsoPlexis Corp ISO Myers Jason W.
Director
89,047 $0 89,047
(Direct)
View

Ownership
2021-10-07
4:59 pm
N/A
2031-07-21
IsoPlexis Corp ISO Myers Jason W.
Director
0 $0 40,000
(Direct)
View
2021-02-19
Gift
2021-02-22
8:47 pm
N/A
N/A
Invitae Corp NVTA Myers Jason W.
Director
310,597 $0 100,000
(Direct)
View
2020-12-17
Gift
2020-12-18
9:32 pm
N/A
N/A
Invitae Corp NVTA Myers Jason W.
President, Oncology
300,000 $0 809,714
(Direct)
View
2020-12-14
Option Award
2020-12-18
9:32 pm
N/A
N/A
Invitae Corp NVTA Myers Jason W.
President, Oncology
324,399 $0 809,714
(Direct)
View
2020-10-02
Option Award
2020-10-05
8:43 pm
N/A
2028-10-01
Invitae Corp NVTA Myers Jason W.
President, Oncology
1,961,483 $0 1,961,483
(Direct)
View